12 Publikationen
-
2021 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2946327Anselmi, M., Borbély, A. N., Figueras Agustí, E., Michalek, C., Kemker, I., Gentilucci, L., & Sewald, N. (2021). Linker Hydrophilicity Modulates the Anticancer Activity of RGD-Cryptophycin Conjugates. Chemistry - A European Journal , 27(3), 1015-1022. https://doi.org/10.1002/chem.202003471
-
2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2940382Borbély, A. N., Thoreau, F., Figueras Agustí, E., Kadri, M., Coll, J. - L., Boturyn, D., & Sewald, N. (2020). Synthesis and Biological Characterization of Monomeric and Tetrameric RGD-Cryptophycin Conjugates. Chemistry - A European Journal, 26(12), 2602-2605. https://doi.org/10.1002/chem.201905437
-
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2936495Borbély, A. N., Figueras Agustí, E., Martins, A., Bodero, L., Raposo Moreira Dias, A., Lopez Rivas, P., Pina, A., et al. (2019). Conjugates of Cryptophycin and RGD or isoDGR Peptidomimetics for Targeted Drug Delivery. ChemistryOpen, 8(6), 737-742. https://doi.org/10.1002/open.201900110
-
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2934762Borbély, A. N., Figueras Agustí, E., Martins, A., Esposito, S., Auciello, G., Monteagudo, E., Di Marco, A., et al. (2019). Synthesis and Biological Evaluation of RGD–Cryptophycin Conjugates for Targeted Drug Delivery. Pharmaceutics, 11(4), 151. https://doi.org/10.3390/pharmaceutics11040151
-
2019 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2935650Figueras Agustí, E., Martins, A., Borbély, A. N., Le Joncour, V., Cordella, P., Perego, R., Modena, D., et al. (2019). Octreotide Conjugates for Tumor Targeting and Imaging. Pharmaceutics, 11(5), 220. https://doi.org/10.3390/pharmaceutics11050220
-
2019 | Bielefelder E-Dissertation | PUB-ID: 2934464Figueras Agustí, E. (2019). Novel cryptophycin analogues and conjugates for tumor targeted therapy . Bielefeld: Universität Bielefeld. https://doi.org/10.4119/unibi/2934464
-
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2920953Figueras Agustí, E., Borbély, A. N., Ismail, M., Frese, M., & Sewald, N. (2018). Novel unit B cryptophycin analogues as payloads for targeted therapy. Beilstein Journal of Organic Chemistry, 14, 1281-1286. https://doi.org/10.3762/bjoc.14.109
-
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2932984Cazzamalli, S., Figueras Agustí, E., Petho, L., Borbély, A. N., Steinkuhler, C., Neri, D., & Sewald, N. (2018). In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas. ACS Omega, 3(11), 14726-14731. https://doi.org/10.1021/acsomega.8b02350
-
2018 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2944897Cazzamalli, S., Figueras Agustí, E., Pethő, L., Borbély, A. N., Steinkühler, C., Neri, D., & Sewald, N. (2018). Correction: In Vivo Antitumor Activity of a Novel Acetazolamide–Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma. ACS Omega, 3(12), 16743-16743. doi:10.1021/acsomega.8b03183
-
2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931993Borbély, A. N., Figueras Agustí, E., Martins, A., Gallinari, P., Esposito, S., Auciello, G., Modena, D., et al. (2018). Novel Cryptophycin-based Conjugates for Tumor Targeting. JOURNAL OF PEPTIDE SCIENCE, 24, S59. Hoboken: Wiley.
-
2018 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2931996Figueras Agustí, E., Martins, A., Borbély, A. N., Gallinari, P., Esposito, S., Auciello, G., Modena, D., et al. (2018). Tumor Targeting of Cryptophycin based Conjugates Using Octreotide as Delivery Vehicle. JOURNAL OF PEPTIDE SCIENCE, 24, S166. Hoboken: Wiley.
-
2017 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2916981Weiss, C., Figueras Agustí, E., Borbély, A. N., & Sewald, N. (2017). Cryptophycins: cytotoxic cyclodepsipeptides with potential for tumor targeting. Journal of Peptide Science, 23(7-8), 514-531. https://doi.org/10.1002/psc.3015